These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19880525)

  • 41. Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation.
    Misra P; Qi C; Yu S; Shah SH; Cao WQ; Rao MS; Thimmapaya B; Zhu Y; Reddy JK
    J Biol Chem; 2002 May; 277(22):20011-9. PubMed ID: 11912212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
    Teufel DP; Freund SM; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.
    Lee CW; Ferreon JC; Ferreon AC; Arai M; Wright PE
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19290-5. PubMed ID: 20962272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NF-κB suppresses HIF-1α response by competing for P300 binding.
    Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
    Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
    Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FBXL5 modulates HIF-1α transcriptional activity by degradation of CITED2.
    Machado-Oliveira G; Guerreiro E; Matias AC; Facucho-Oliveira J; Pacheco-Leyva I; Bragança J
    Arch Biochem Biophys; 2015 Jun; 576():61-72. PubMed ID: 25956243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EAF2 suppresses hypoxia-induced factor 1α transcriptional activity by disrupting its interaction with coactivator CBP/p300.
    Chen Z; Liu X; Mei Z; Wang Z; Xiao W
    Mol Cell Biol; 2014 Mar; 34(6):1085-99. PubMed ID: 24421387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1.
    Seo HW; Kim EJ; Na H; Lee MO
    FEBS Lett; 2009 Jan; 583(1):55-60. PubMed ID: 19071119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.
    Luo W; Hu H; Chang R; Zhong J; Knabel M; O'Meally R; Cole RN; Pandey A; Semenza GL
    Cell; 2011 May; 145(5):732-44. PubMed ID: 21620138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
    Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
    Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.
    Stiehl DP; Fath DM; Liang D; Jiang Y; Sang N
    Cancer Res; 2007 Mar; 67(5):2256-2264. PubMed ID: 17332356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression.
    Wadgaonkar R; Collins T
    J Biol Chem; 1999 May; 274(20):13760-7. PubMed ID: 10318779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
    Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
    Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of CBP in regulating HIF-1-mediated activation of transcription.
    Ruas JL; Poellinger L; Pereira T
    J Cell Sci; 2005 Jan; 118(Pt 2):301-11. PubMed ID: 15615775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription.
    Mukherjee SP; Behar M; Birnbaum HA; Hoffmann A; Wright PE; Ghosh G
    PLoS Biol; 2013 Sep; 11(9):e1001647. PubMed ID: 24019758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites.
    De Guzman RN; Martinez-Yamout MA; Dyson HJ; Wright PE
    J Biol Chem; 2004 Jan; 279(4):3042-9. PubMed ID: 14594809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1.
    Lee JH; Volinic JL; Banz C; Yao KM; Thomas MK
    J Endocrinol; 2005 Nov; 187(2):283-92. PubMed ID: 16293776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 Transcriptional activity is mediated through the SRC1-interacting domain of CBP/p300.
    Livengood JA; Scoggin KE; Van Orden K; McBryant SJ; Edayathumangalam RS; Laybourn PJ; Nyborg JK
    J Biol Chem; 2002 Mar; 277(11):9054-61. PubMed ID: 11782467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
    Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.